API Technology Transfer
Midas Pharma offers complete end-to-end solutions for a technology transfer based on different models of co-operation, license and supply. Each project set-up is unique, based on the project targets and thorough analysis of available know-how.
Following consultation with in-house experts and in close cooperation with you, we provide tailor-made solutions for your particular expectations of the targeted transfer.
We offer a range of models covering e.g. the transfer of process and analytical know-how for an API (or IM-Intermediate) at any stage of the substance lifecycle (lab, pilot, commercial phase).
The transfer can be carried out for you on an exclusive basis (e.g. outsourcing/ site transfer) as a contract development and/or contract manufacture based on your needs.
Alternatively, Midas is also interested in licensing-in technologies from partners, e.g. in case of:
- a hard exit - discontinuation of production, site closure at your end, or
- a soft exit - models which include covering your captive demands at favorable conditions
In case of a licensing-in, the investments for implementation, validation, registration, and manufacture are fully borne by Midas. You benefit at no risk!